 The purpose of this study is to assess specific immunological changes IgG, IgG1, IgG4 and IgE in allergic subjects following 2 subcutaneous injections of different doses of study medication Tree MATA or placebo administered 3 weeks apart. The immunological changes will be used to assess the performance of the R7 IgG reactivity assay over a range of clinically efficacious doses. 